Recro

About Recro

Recro® provides oral solid dosage form development, regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. Specializing in modified release oral solid dose and DEA controlled substances, Recro has the experts to deliver clients’ most complex pharmaceutical development, manufacturing, and packaging projects in its best-in-class, 120,000-square-foot manufacturing facility. For more information about Recro’s flexible CDMO solutions, visit www.recrocdmo.com.

  • US
  • 2017
    On CPhI since
  • 100 - 249
    Employees
Contact info

Recro Resources